340 related articles for article (PubMed ID: 23385241)
1. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission.
Rajilić-Stojanović M; Shanahan F; Guarner F; de Vos WM
Inflamm Bowel Dis; 2013 Mar; 19(3):481-8. PubMed ID: 23385241
[TBL] [Abstract][Full Text] [Related]
2. The oral bacterial microbiota facilitates the stratification for ulcerative colitis patients with oral ulcers.
Xu J; Zhang Y; Fang XH; Liu Y; Huang YB; Ke ZL; Wang Y; Zhang YF; Zhang Y; Zhou JH; Su HT; Chen N; Liu YL
Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):99. PubMed ID: 37946238
[TBL] [Abstract][Full Text] [Related]
3. Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis.
Galipeau HJ; Caminero A; Turpin W; Bermudez-Brito M; Santiago A; Libertucci J; Constante M; Raygoza Garay JA; Rueda G; Armstrong S; Clarizio A; Smith MI; Surette MG; Bercik P; ; Croitoru K; Verdu EF
Gastroenterology; 2021 Apr; 160(5):1532-1545. PubMed ID: 33310084
[TBL] [Abstract][Full Text] [Related]
4. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation.
Fuentes S; Rossen NG; van der Spek MJ; Hartman JH; Huuskonen L; Korpela K; Salojärvi J; Aalvink S; de Vos WM; D'Haens GR; Zoetendal EG; Ponsioen CY
ISME J; 2017 Aug; 11(8):1877-1889. PubMed ID: 28398347
[TBL] [Abstract][Full Text] [Related]
5. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response.
Haberman Y; Karns R; Dexheimer PJ; Schirmer M; Somekh J; Jurickova I; Braun T; Novak E; Bauman L; Collins MH; Mo A; Rosen MJ; Bonkowski E; Gotman N; Marquis A; Nistel M; Rufo PA; Baker SS; Sauer CG; Markowitz J; Pfefferkorn MD; Rosh JR; Boyle BM; Mack DR; Baldassano RN; Shah S; Leleiko NS; Heyman MB; Grifiths AM; Patel AS; Noe JD; Aronow BJ; Kugathasan S; Walters TD; Gibson G; Thomas SD; Mollen K; Shen-Orr S; Huttenhower C; Xavier RJ; Hyams JS; Denson LA
Nat Commun; 2019 Jan; 10(1):38. PubMed ID: 30604764
[TBL] [Abstract][Full Text] [Related]
6. Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with Crohn's disease.
Li Q; Wang C; Tang C; Li N; Li J
PLoS One; 2012; 7(4):e34939. PubMed ID: 22529960
[TBL] [Abstract][Full Text] [Related]
7. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course.
Schirmer M; Denson L; Vlamakis H; Franzosa EA; Thomas S; Gotman NM; Rufo P; Baker SS; Sauer C; Markowitz J; Pfefferkorn M; Oliva-Hemker M; Rosh J; Otley A; Boyle B; Mack D; Baldassano R; Keljo D; LeLeiko N; Heyman M; Griffiths A; Patel AS; Noe J; Kugathasan S; Walters T; Huttenhower C; Hyams J; Xavier RJ
Cell Host Microbe; 2018 Oct; 24(4):600-610.e4. PubMed ID: 30308161
[TBL] [Abstract][Full Text] [Related]
8. Ulcerative Colitis Seems to Imply Oral Microbiome Dysbiosis.
Molinero N; Taladrid D; Zorraquín-Peña I; de Celis M; Belda I; Mira A; Bartolomé B; Moreno-Arribas MV
Curr Issues Mol Biol; 2022 Mar; 44(4):1513-1527. PubMed ID: 35723361
[TBL] [Abstract][Full Text] [Related]
9. Bacterial dysbiosis in newly diagnosed treatment naïve pediatric ulcerative colitis in Saudi Arabia.
El Mouzan M; Al Mofarreh M; Alsaleem B; Al Sarkhy A; Alanazi A; Khormi M; Almasoud A; Assiri A
Saudi J Gastroenterol; 2024 May; ():. PubMed ID: 38708883
[TBL] [Abstract][Full Text] [Related]
10. Microbiota-nourishing Immunity and Its Relevance for Ulcerative Colitis.
Byndloss MX; Litvak Y; Bäumler AJ
Inflamm Bowel Dis; 2019 Apr; 25(5):811-815. PubMed ID: 30698700
[TBL] [Abstract][Full Text] [Related]
11. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Machiels K; Joossens M; Sabino J; De Preter V; Arijs I; Eeckhaut V; Ballet V; Claes K; Van Immerseel F; Verbeke K; Ferrante M; Verhaegen J; Rutgeerts P; Vermeire S
Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287
[TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.
Moayyedi P; Surette MG; Kim PT; Libertucci J; Wolfe M; Onischi C; Armstrong D; Marshall JK; Kassam Z; Reinisch W; Lee CH
Gastroenterology; 2015 Jul; 149(1):102-109.e6. PubMed ID: 25857665
[TBL] [Abstract][Full Text] [Related]
13. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease.
Wang W; Chen L; Zhou R; Wang X; Song L; Huang S; Wang G; Xia B
J Clin Microbiol; 2014 Feb; 52(2):398-406. PubMed ID: 24478468
[TBL] [Abstract][Full Text] [Related]
14. The microbiome in inflammatory bowel disease: current status and the future ahead.
Kostic AD; Xavier RJ; Gevers D
Gastroenterology; 2014 May; 146(6):1489-99. PubMed ID: 24560869
[TBL] [Abstract][Full Text] [Related]
15. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease.
Tong M; Li X; Wegener Parfrey L; Roth B; Ippoliti A; Wei B; Borneman J; McGovern DP; Frank DN; Li E; Horvath S; Knight R; Braun J
PLoS One; 2013; 8(11):e80702. PubMed ID: 24260458
[TBL] [Abstract][Full Text] [Related]
16. Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers.
Lavelle A; Lennon G; O'Sullivan O; Docherty N; Balfe A; Maguire A; Mulcahy HE; Doherty G; O'Donoghue D; Hyland J; Ross RP; Coffey JC; Sheahan K; Cotter PD; Shanahan F; Winter DC; O'Connell PR
Gut; 2015 Oct; 64(10):1553-61. PubMed ID: 25596182
[TBL] [Abstract][Full Text] [Related]
17. The treatment-naive microbiome in new-onset Crohn's disease.
Gevers D; Kugathasan S; Denson LA; Vázquez-Baeza Y; Van Treuren W; Ren B; Schwager E; Knights D; Song SJ; Yassour M; Morgan XC; Kostic AD; Luo C; González A; McDonald D; Haberman Y; Walters T; Baker S; Rosh J; Stephens M; Heyman M; Markowitz J; Baldassano R; Griffiths A; Sylvester F; Mack D; Kim S; Crandall W; Hyams J; Huttenhower C; Knight R; Xavier RJ
Cell Host Microbe; 2014 Mar; 15(3):382-392. PubMed ID: 24629344
[TBL] [Abstract][Full Text] [Related]
18. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.
Scher JU; Ubeda C; Artacho A; Attur M; Isaac S; Reddy SM; Marmon S; Neimann A; Brusca S; Patel T; Manasson J; Pamer EG; Littman DR; Abramson SB
Arthritis Rheumatol; 2015 Jan; 67(1):128-39. PubMed ID: 25319745
[TBL] [Abstract][Full Text] [Related]
19. Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.
Kolho KL; Korpela K; Jaakkola T; Pichai MV; Zoetendal EG; Salonen A; de Vos WM
Am J Gastroenterol; 2015 Jun; 110(6):921-30. PubMed ID: 25986361
[TBL] [Abstract][Full Text] [Related]
20. Role of the gut microbiota in immunity and inflammatory disease.
Kamada N; Seo SU; Chen GY; Núñez G
Nat Rev Immunol; 2013 May; 13(5):321-35. PubMed ID: 23618829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
